DanCann Pharma A/S (NGM:DANCAN)

DanCann Pharma Revenue

DanCann Pharma had revenue of 1.18M DKK in the quarter ending June 30, 2025, a decrease of -69.35%. This brings the company's revenue in the last twelve months to 4.25M, down -47.05% year-over-year. In the year 2024, DanCann Pharma had annual revenue of 7.37M with 3.06% growth.

• Revenue (ttm): 4.25M DKK
• Revenue Growth: -47.05%
• P/S Ratio: 0.22
• Revenue / Employee: 849.60K DKK
• Employees: 5
• Market Cap: 1.30M SEK

Revenue Chart

* This company reports financials in DKK.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	7.37M	219.00K	3.06%
Dec 31, 2023	7.15M	-36.00K	-0.50%
Dec 31, 2022	7.19M	4.88M	211.89%
Dec 31, 2021	2.31M	-	-
Dec 31, 2020	-	-	-